array:22 [ "pii" => "S002577530071270X" "issn" => "00257753" "doi" => "10.1016/S0025-7753(00)71270-X" "estado" => "S300" "fechaPublicacion" => "2000-01-01" "aid" => "71270" "copyright" => "Elsevier España, S.L.. Todos los derechos reservados" "copyrightAnyo" => "2000" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Med Clin. 2000;114:281-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2007 "formatos" => array:3 [ "EPUB" => 6 "HTML" => 1852 "PDF" => 149 ] ] "itemSiguiente" => array:18 [ "pii" => "S0025775300712711" "issn" => "00257753" "doi" => "10.1016/S0025-7753(00)71271-1" "estado" => "S300" "fechaPublicacion" => "2000-01-01" "aid" => "71271" "copyright" => "Elsevier España, S.L." "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Med Clin. 2000;114:286-91" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2982 "formatos" => array:3 [ "EPUB" => 6 "HTML" => 2863 "PDF" => 113 ] ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Originales</span>" "titulo" => "Estimación de la prevalencia de infección por VIH-1 en la embarazada y efectividad de la zidovudina administrada durante la gestación en la prevención de la transmisión vertical" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "286" "paginaFinal" => "291" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Estimate of the HIV-1 prevalence in pregnant women and effectiveness of zidovudine administered during pregnancy in reducing perinatal transmission" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José Tomás Ramos Amador, Jesús Ruiz Contreras, Rafael Bastero, Carmen Barrio, Pilar Moreno, Rafael Delgado, Eloy Muñoz, Jesús Jiménez" "autores" => array:8 [ 0 => array:2 [ "nombre" => "José Tomás" "apellidos" => "Ramos Amador" ] 1 => array:2 [ "nombre" => "Jesús Ruiz" "apellidos" => "Contreras" ] 2 => array:2 [ "nombre" => "Rafael" "apellidos" => "Bastero" ] 3 => array:2 [ "nombre" => "Carmen" "apellidos" => "Barrio" ] 4 => array:2 [ "nombre" => "Pilar" "apellidos" => "Moreno" ] 5 => array:2 [ "nombre" => "Rafael" "apellidos" => "Delgado" ] 6 => array:2 [ "nombre" => "Eloy" "apellidos" => "Muñoz" ] 7 => array:2 [ "nombre" => "Jesús" "apellidos" => "Jiménez" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775300712711?idApp=UINPBA00004N" "url" => "/00257753/0000011400000008/v1_201307291447/S0025775300712711/v1_201307291447/es/main.assets" ] "es" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Originales</span>" "titulo" => "Monitorización de la enfermedad mínima residual mediante detección conjunta de los reordenamientos <span class="elsevierStyleItalic">PML/RARα</span> y <span class="elsevierStyleItalic">RARα/PML</span> en la leucemia promielocítica aguda" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "281" "paginaFinal" => "285" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Pascual Bolufer,, Eva Barragán, Miguel Ángel Sanz, Guillermo Martín, Enrique Lerma, Esperanza Afán de Ribera" "autores" => array:6 [ 0 => array:4 [ "nombre" => "Pascual" "apellidos" => "Bolufer," "email" => array:1 [ 0 => "boluferpas@gva.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff00005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Eva" "apellidos" => "Barragán" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff00005" ] ] ] 2 => array:3 [ "nombre" => "Miguel" "apellidos" => "Ángel Sanz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff00010" ] ] ] 3 => array:3 [ "nombre" => "Guillermo" "apellidos" => "Martín" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff00010" ] ] ] 4 => array:3 [ "nombre" => "Enrique" "apellidos" => "Lerma" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff00005" ] ] ] 5 => array:3 [ "nombre" => "Esperanza" "apellidos" => "Afán de Ribera" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff00005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "<span class="elsevierStyleItalic">Laboratorio de Biología Molecular. Departamento de Biopatología Clínica</span>" "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff00005" ] 1 => array:3 [ "entidad" => "<span class="elsevierStyleItalic">Sección de Hematología Clínica. Servicio de Hematología y Hemoterapia. Hospital Universitario La Fe. Valencia</span>" "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff00010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "*" "correspondencia" => "Correspondencia: Dr. P. Bolufer Gilabert. Laboratorio de Biología Molecular (Laboratorio de Hormonas). Centro Maternal. Hospital Universitario La Fe. Avda. Campanar, 21. 46009 Valencia" ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Monitoring of minimal residual disease by combined detection of PML/RARα and RARα/PML rearrangements in acute promyelocytic leukemia" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "1999-08-27" "fechaAceptado" => "2000-01-20" "PalabrasClave" => array:1 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec221300" "palabras" => array:5 [ 0 => "RARa/PML" 1 => "PML/RARa" 2 => "Leucemia promielocítica aguda" 3 => "Monitorización" 4 => "Enfermedad mínima residual" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:1 [ "resumen" => "<span class="elsevierStyleSectionTitle">Fundamento</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">: La ajustada sensibilidad del metodo de RT-PCR empleado en la deteccion del reordenamientoPML/RARα en la leucemia promielocitica aguda (LPA), en comparacion con lamayor sensibilidad alcanzada para otros reordenamientos, justifico que en el presente estudiose planteara la monitorizacion de la enfermedad minima residual (EMR) en la LPA determinandoconjuntamente el reordenamiento RARα y el RARα/PML.</p> <span class="elsevierStyleSectionTitle">Pacientes Y Métodos</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">: Se incluyeron 56 pacientes con LPA tratados siguiendo el protocolo PETHEMALPA-96. La deteccion de PML/RARα se efectuo segun el metodo de Biondi et al y la deRARα/PML siguiendo el procedimiento de Grimwade D et al (Human Press Inc.).</p> <span class="elsevierStyleSectionTitle">Resultados</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">: RARα/PML se detecto en el 90% (20/22) de los pacientes al diagnostico positivopara PML/RARα. En la postinduccion, RARα/PML se detecto en el 74% de los pacientes(14/19) frente al 37% (7/19) de PML/RARα. Asimismo, en algunas muestras en la posconsolidacion(2/11) se detecto RARα/PML, siendo negativas para PML/RARα. En los pacientes enmantenimiento se detecto una mayor proporcion de positividades (6/28) para RARα/PML quepara PML/RARα (2/28). En un paciente en remision completa, RARα/PML precedio a la apariciondel PML/RARα y persistio un mayor tiempo tras la negativizacion de PML/RARα. En elgrupo de pacientes seguidos desde el diagnostico se observo que RARα/PML suele negativizarseun mes despues de la negativizacion de PML/RARα.</p> <span class="elsevierStyleSectionTitle">Conclusiones</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">: RARα/PML se expresa en el 90% de los pacientes con LPA al diagnostico.RARα/PML se detecta en una mayor proporcion de muestras recogidas durante la evolucion quePML/RARα. RARα/PML persiste un mayor tiempo que PML/RARα tras el tratamiento inicial.</p>" ] "en" => array:1 [ "resumen" => "<span class="elsevierStyleSectionTitle">Background</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">: Molecular assay commonly used to detect the PML/RARá rearrangement in acutepromyelocytic leukemia (APL) has the limited sensitivity in comparison with the higher sensitivityof RARá/PML detection. This prompted us to perform both assays in parallel to monitor agroup of APL.</p> <span class="elsevierStyleSectionTitle">Patients and Methods</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">: The study included 56 APL patients mainly treated according with thePETHEMA LPA-96 protocol. The PML/RARá was detected according with Biondi's et al methodand the RARá/PML following the Grimwade's et al RT-PCR method (Human Press Inc.).</p> <span class="elsevierStyleSectionTitle">Results</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">: RARá/PML rearrangement was detected in 90% (20/22) of the patients at diagnosis positivesfor PML/RARá. RARá/PML was detected in 74%(14/19) of post-induction samples versus37% (7/19) of positives for PML/RARá. Likewise RARá/PML rearrangement was detected in somepost-consolidation samples (2/11) that all were PMI/RARá negatives. In patients in maintenanceregimen a greater proportion of RARá/PML positives (6/28) versus PML/RARá (2/28) were observed.In a patient in complete remission RARá/PML preceded the positivity of PML/RARá and persistedafter PMI/RARá negativization. The results of the patients monitored since the diagnosisshowed that RARá/PML revert to negative one month after PML/RARá negativization.</p> <span class="elsevierStyleSectionTitle">Conclusions</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">: RARá/PML rearrangement is not expressed in the totality of the APL patients, butin only a 90% of them. RARá/PML rearrangement was detected in a greater proportion of samplesthan PML/RARá. RARá/PML rearrangement lasted longer than PML/RARá after treatment.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Referencias Bibliográficas" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:15 [ 0 => array:3 [ "identificador" => "bib00005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The balanced and unbalanced chromosome of acute leukemia may develop different ways and may contribute differently to malignant transformation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Pedersen-Bjergaard" 1 => "J.D. Rowley" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Blood" "fecha" => "1994" "volumen" => "83" "paginaInicial" => "2780" "paginaFinal" => "2786" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8180374" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib00010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The biology and therapy of acute myelogenous leukemias. ASH. Educational Programme" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "F.R. Appelbaum" 1 => "J. Downing" 2 => "C. William" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Seattle" "fecha" => "1995" "paginaInicial" => "23" "paginaFinal" => "25" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib00015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "RT-PCR in diagnosis and disease monitoring of acute promyelocytic leukemia (APL)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "D. Grimwade" 1 => "S. Langabeer" 2 => "K. Howe" 3 => "E. Solomon" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:4 [ "titulo" => "Methods in molecular biology" "paginaInicial" => "333" "paginaFinal" => "358" "serieFecha" => "1997" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib00020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance [revision]" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D. Campana" 1 => "Ch. Pui" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Blood" "fecha" => "1995" "volumen" => "85" "paginaInicial" => "1416" "paginaFinal" => "1434" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7888664" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib00025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Minimal residual disease after allogenic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations acute graft-versus-host disease and relapse" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "N.C.P. Cross" 1 => "T.P. Hughes" 2 => "L. Feng" 3 => "P. O'Shea" 4 => "J. Bungey" 5 => "D.I. Marks" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Brit J Haematol" "fecha" => "1993" "volumen" => "84" "paginaInicial" => "67" "paginaFinal" => "74" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib00030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "for the PETHEMA Group. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARα-positive acute promyelocytic leukemia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "M.A. Sanz" 1 => "G. Martin" 2 => "C. Rayon" 3 => "J. Esteve" 4 => "M. Gonzalez" 5 => "J. Diaz-Mediavilla" 6 => "a.l. et" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Blood" "fecha" => "1999" "volumen" => "94" "paginaInicial" => "3015" "paginaFinal" => "3021" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10556184" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib00035" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Molecular evaluation of residual disease as predictor of relapse in acute promyelocytik leukemia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Lo Coco" 1 => "D. Diverjo" 2 => "P. Pandolfi" 3 => "A. Biondi" 4 => "V. Rossi" 5 => "G. Avvisati" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "1992" "volumen" => "340" "paginaInicial" => "1437" "paginaFinal" => "1438" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1360562" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib00040" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute promyelocytic leukemia: a curable disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "F. Lo Coco" 1 => "C. Nervi" 2 => "G. Avvisati" 3 => "F. Mandelli" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Leukemia" "fecha" => "1998" "volumen" => "2" "paginaInicial" => "1866" "paginaFinal" => "1880" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib00045" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cross NCP. Quantitation of PMLRARα transcripts in acute promyelocytic leukaemia: explanation for the lack of sensitivity of RTPCR for the detection of minimal residual disease and induction of the leukaemia-specific mRNA by alpha interpheron" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J.R.C. Seale" 1 => "S. Varma" 2 => "D.M. Swirsky" 3 => "P.P. Pandolfi" 4 => "J.M. Goldman" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Brit J Haemat" "fecha" => "1996" "volumen" => "95" "paginaInicial" => "95" "paginaFinal" => "101" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8857944" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib00050" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Single-step method of RNA isolation by acid guanidium thiocyanatephenol-chloroform extraction" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "P. Chomczynski" 1 => "N. Sacchi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1006/abio.1987.9999" "Revista" => array:6 [ "tituloSerie" => "Anal Biochem" "fecha" => "1987" "volumen" => "162" "paginaInicial" => "156" "paginaFinal" => "159" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2440339" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib00055" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Expression pattern of the RARα/PML fusion gene in acute promyelocytic leukemia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Alcalay" 1 => "D. Zangrilli" 2 => "M. Fagioli" 3 => "P.P. Pandolfi" 4 => "A. Mencarelli" 5 => "F. Lo Coco" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Proc Natl Acad Sci USA" "fecha" => "1992" "volumen" => "89" "paginaInicial" => "4840" "paginaFinal" => "4844" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1317574" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib00060" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Lo Coco" 1 => "D. Diverio" 2 => "P.P. Pandolfi" 3 => "A. Biondi" 4 => "V. Rossi" 5 => "G. Avvisati" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "1992" "volumen" => "340" "paginaInicial" => "1437" "paginaFinal" => "1438" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1360562" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib00065" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Molecular monitoring of the myl/retinoic acid receptor-α fusion gene in acute promyelocytic leukemia by polymerase chain reaction" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Biondi" 1 => "A. Rambaldi" 2 => "P.P. Pandolfi" 3 => "V. Rosi" 4 => "G. Giudici" 5 => "M. Alcalay" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Blood" "fecha" => "1992" "volumen" => "80" "paginaInicial" => "492" "paginaFinal" => "497" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1320955" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib00070" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Deteccion del reordenamiento PML/RARα en la leucemia promielocitica aguda mediante un metodo de PCR reversa" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "W.E. Barragan" 1 => "S. Bonanad" 2 => "J.A. Lopez" 3 => "G. Martin" 4 => "J. Martinez" 5 => "G.F. Sanz" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Sangre" "fecha" => "1996" "volumen" => "41" "paginaInicial" => "189" "paginaFinal" => "194" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8755206" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib00075" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Minimal residual disease detection in acute promyelocytic leukemia by reverse transcriptase PCR: evaluation of PML-RARα and RARα-PML assessment in patients who ultimately relapse" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "D. Grimwade" 1 => "K. Howe" 2 => "S. Langebeer" 3 => "A.K. Burnett" 4 => "A. Goldsetone" 5 => "E. Solomon" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Leukemia" "fecha" => "1996" "volumen" => "10" "paginaInicial" => "61" "paginaFinal" => "66" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8558940" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/00257753/0000011400000008/v1_201307291447/S002577530071270X/v1_201307291447/es/main.assets" "Apartado" => array:4 [ "identificador" => "24087" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Original breve" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/00257753/0000011400000008/v1_201307291447/S002577530071270X/v1_201307291447/es/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S002577530071270X?idApp=UINPBA00004N" ]
Información de la revista
Compartir
Descargar PDF
Más opciones de artículo
Originales
Monitorización de la enfermedad mínima residual mediante detección conjunta de los reordenamientos PML/RARα y RARα/PML en la leucemia promielocítica aguda
Monitoring of minimal residual disease by combined detection of PML/RARα and RARα/PML rearrangements in acute promyelocytic leukemia
Pascual Bolufer,a,
, Eva Barragána, Miguel Ángel Sanzb, Guillermo Martínb, Enrique Lermaa, Esperanza Afán de Riberaa
Autor para correspondencia
boluferpas@gva.es
Correspondencia: Dr. P. Bolufer Gilabert. Laboratorio de Biología Molecular (Laboratorio de Hormonas). Centro Maternal. Hospital Universitario La Fe. Avda. Campanar, 21. 46009 Valencia
Correspondencia: Dr. P. Bolufer Gilabert. Laboratorio de Biología Molecular (Laboratorio de Hormonas). Centro Maternal. Hospital Universitario La Fe. Avda. Campanar, 21. 46009 Valencia